Whitepaper
23 Sep 2020

New laboratory and regulatory services for biotech customers

DOCX 2.3 MB

Gx Biological Solutions offers enhanced services for pharmaceutical primary packaging in the US and in Europe.

Content provided by our supplier

Gerresheimer AG

  • DE
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Contract Service
Manufacturer/Innovator

Other Content from Gerresheimer AG (22)

  • News Gerresheimer at CPHI Worldwide: global presence for innovative and sustainable solutions for biotech and pharma

    Düsseldorf, Germany, October 21, 2021. Gerresheimer's global presence in Europe, America and Asia at numerous certified own production sites enables regional and market-oriented cooperation and logistics with partners in the pharma world. At CPHI Worldwide in Milano the company will be presenting its innovative, solution-oriented and sustainable developments. The wide range of products includes solutions, products and delivery systems for drugs, vaccines or high potency biologics.
  • Brochure Customer Newsletter

    Latest news and innovations in the world of Gerresheimer. 
  • Brochure Primary Packaging Glass - Gx® Ready-to-fill Vials

    Gx® RTF vials are washed, packed in trays or in a nest and tub, sterilized and delivered to pharmaceuticals customers. They can then immediately begin filling without further procees steps. Gx RTF® Vials: flexibility through different packaging configurationshighest quality requirementshighest standards with regard to glass breakage, cosmetic defects, paricle contaminationDelivered sterilePackaging based on Ompi EZ-fill packaging formats: identically packaged sterile vials from to different manufacturers
  • Brochure Primary Packaging Glass - Metal-free glass syringes

    One problem associated with syringe use is that traces of tungsten or other metals occasionally leave residue behind in the bore when the syringe cone is shaped. Gerresheimer developed a production technology registered for patent where the pin used to shape the cone is made of a special ceramic. So we can offer a metal-free 1 ml Gx RTF® Luer lock glass syringe. The process can be transferred to other Luer lock syringe sizes or to Luer cone syringes of various sizes at any time.
  • Brochure Primary Packaging - RTF® ClearJect® polymer syringes

    The syringes are made from COP (Cyclo Olefin Polymer). The needle syringes are glue-free as the cannula is not glued in, but is instead insert-molded during the injection molding process. No aggregation due to metal or tungsten residues, high viscosity silicone oil for reduced particles, minimal extractables and leachables, high pH tolerance, no shift in pH value, optimized permeation rate, high break resistance, tighter tolerances than glass, precise medication dosing thanks to minimal residue volume, wide variety of design options and high flexibility for customer-specific requirements, outstanding syringe functionality with regard to break loose, gliding forces and pull-off forces of the needle shield, compatible with auto injectors.
  • Brochure Primary Packaging Glass and Plastic - Gx® prefillable syringes

    Prefillable glass syringes in bulk and "ready-to-fill" format, filling volumes of 0.5 to 5.0 ml, luer cone and luer lock systems, needle syringes, silicone-oil reduced and metal-free syringes for sensitive active ingredients, innovative syringe components.
  • Brochure Primary Packaging Glass - Gx InnoSafe® syringes

    With Gx InnoSafe, Gerresheimer offers a syringe with an integrated safety systems that prevents unintentional needle stick injuriesexcludes the possibility of accidental reuse andtakes the needs of pharmaceutical companies and end users equally into account.
  • Brochure Customized Drug Delivery Systems, Medical and Diagnostic Products

    From the concept development through industrialization to assembly, and pharmaceutical filling. We cover the entire spectrum of delivery types: inhaler, syringes, pen systems, auto injectors and infusion sets


  • Brochure Liquid Drug Delivery Solutions

    Sensile Medical is a pioneer in liquid drug delivery pump devices with a  typical total volume of 3 – 20 ml. The subcutaneous medication at home combined with digital solutions is attractive for all stakeholders of the health care system.



  • Whitepaper Biological Solutions

    Dedicated primary packaging for biological active ingredients : from reduced silicone- , and polymer syringes over ready-to-fill glass- and COP vials to customized product developments  and much more.


  • Whitepaper Global Player

    We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. We have plants in Europe, North America, South America and Asia. This Whitepaper is a map of our worldwide locations.
  • Video Services Beyond Product

    Next to the primary packaging container itself services and data are needed, to proof usability and allow registration. Chemical, functionality, physical and regulatory aspects have to be covered in the complete value chain. Support on registration, lifecycle management, continuous improvement and more are offered by Gerresheimer. Let’s go through the capabilities of an experienced supplierThis webinar originally aired as part of Pharmapack Europe 2021
  • Video Corporate Image Video

    This video shows how we are transforming our company into a growth asset as an innovatins leader and solutions provider.
  • Webinar On the Road to Decarbonisation - Gerresheimer Moulded Glass

    The presentation will be about the Gerresheimer – roadmap to decarbonization. The speaker will cover supplier-specific approaches like the furnace technology. Furthermore, Value-chain-comprising approaches in Ph-business (eg eco-design development) will be explained. In the end, success stories about joint value-chain comprising decarbonisation will be told. This session was broadcast as part of the Pharmapack show.
  • Webinar Technology & Device Trends Driving Care from Hospital to Home

    Smart devices which enable remote monitoring and self-administration have been on the market for a few years, but pandemic has fast-tracked growth in this sector. At a time when visiting a hospital to receive care was potentially dangerous for more vulnerable patients, and health centres were overwhelmed and lacked capacity, focus shifted to devices and solutions which would enable safe administration of medications in the home setting. This webinar will examine the future of ‘patient-centric’ telemedicine solutions – from the most innovative devices entering the market, to the role of logistics companies in creating a new infrastructure around remote care. By attending this webinar, you will understand more about: The impact of COVID on ‘home health’ and remote monitoring Device innovation – what are the latest products entering the market Maintaining adherence at home Supporting the logistical requirements of home healthcare